Federal grants to W-Z Biotech LLC
W-Z Biotech LLC in Lexington, Kentucky received $3.7 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Cardiovascular Diseases Research, with $3.7 million. In fiscal 2025 it was awarded $1.6 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$3.7 million
- Awards4
- Awarded in FY 2025$1.6 million
- Largest award$2.9 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $225,000 |
| FY 2022 | 0 | $0 |
| FY 2023 | 2 | $571,277 |
| FY 2024 | 1 | $1.3 million |
| FY 2025 | 1 | $1.6 million |
Programs that fund W-Z Biotech LLC
| Program | Awards | Amount |
|---|---|---|
| Cardiovascular Diseases Research | 4 | $3.7 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $3.7 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Development of a minimally invasive single cannulation, compact single port pulsatile ventricular assist device (SPPVAD) for total lv support - cardiogenic shock (CS) is a serious condition of low cardiac output with a 40-50% mortality. In severe cs, hypoperfusion causes multi-organ failure and high | Cardiovascular Diseases Research | September 17, 2024 | $2.9 million |
| Integration of compliance chambers into diaphragm displacement pump to double the pumping flow of pediatric paracorporeal pulsatile ventricular assist device - the paracorporeal berlin heart excor is the only fda-approved ventricular assist device (VAD) for pediatric patients. This pulsatile diaphra | Cardiovascular Diseases Research | August 10, 2023 | $295,583 |
| Pediatric transapical double lumen cannula with integrated compliance chambers doubles flow of paracorporeal pulsatile vad - pediatric patients with severe heart failure require a ventricular assist device (VAD). The paracorporeal berlin heart excor is still the only fda-approved vad for pediatric p | Cardiovascular Diseases Research | May 11, 2023 | $275,355 |
| Development of a minimally invasive single cannulation, compact single port pulsatile ventricular assist device (SPPVAD) for total lv support - cardiogenic shock (CS) is a serious condition of reduced cardiac output (CO) with a mortality as high as 40-50%. In severe cs, end organ hypoperfusion from | Cardiovascular Diseases Research | March 19, 2021 | $225,000 |
Questions people ask
How much federal grant money does W-Z Biotech LLC get?
$3.7 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives W-Z Biotech LLC the most?
The Department of Health and Human Services, with $3.7 million in 4 awards.
What is W-Z Biotech LLC's largest federal grant?
$2.9 million under Cardiovascular Diseases Research, with its first action in the period on September 17, 2024. That counts only the money obligated in fiscal 2021 to 2025.
Other grant recipients in Lexington
- The University of Kentucky Research Foundation
- Community Action Council for Lexington-F
- The University of Kentucky Research Foundation
- The Council of State Governments LTD.
- Lexington-Fayette Urban County Airport Board
- Kentucky Utilities Company
- Lexington-Fayette Urban County Government
- Transit Authority of Lexington-Fayette County Urban County Government
Largest federal grant recipients in Kentucky · Federal grants in Kentucky